Last edition
News about "MV Ramana"
Takeda and Dr. Reddy's Partner to Sell QDENGA in India
Takeda and Dr. Reddy's Laboratories have entered into an exclusive collaboration to promote and distribute QDENGA in India's pediatric and adult private market.
MV Ramana | 19/09/2026 | By News Bureau
Dr. Reddy's launches NIVORZ in India
Dr. Reddy’s has launched NIVORZ, a nivolumab biosimilar in India, marking its entry into biosimilar immuno-oncology with approval across 12 cancer indications.
M.V. Ramana | 16/09/2026 | By News Bureau
Dr. Reddy's Launches Oral Semaglutide Biosimilar Obeda Tablets in India
Dr. Reddy's launches Obeda oral semaglutide tablets in India, strengthening its GLP-1 portfolio after recent generic semaglutide injection launches in India and Canada for diabetes and obesity care.
MV Ramana | 20/05/2026 | By News Bureau | 252
Dr Reddy's Launches Recombinant Hepatitis E Vaccine Hevaxin in India
According to Dr Reddy’s, clinical studies show that Hevaxin offers protective efficacy, durable immunity, and a favourable immune response, supported by an established safety and tolerability profile.
MV Ramana | 07/01/2026 | By News Bureau | 239
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy